Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
1.
Pathogens ; 9(12)2020 Nov 30.
Article in English | MEDLINE | ID: mdl-33265947

ABSTRACT

A man with a well-controlled HIV infection, previously diagnosed with lymphogranuloma venereum and treated for Hodgkin's lymphoma, was suffering from chronic diarrhea. He travelled to Indonesia in the month prior to the start of complaints. Over a 15-month period, sequences related to Campylobactertroglodytis/upsaliensis, C. pinnepediorum/mucosalis/concisus and C. hominis were detected by 16S rRNA qPCR-based assays in various stool samples and in a colon biopsy. Culture revealed the first isolation of "candidatus Campylobacter infans", a species identified recently by molecular methods only. The patient was treated with azithromycin, ciprofloxacin and tetracycline. To identify potential continuous exposure of the patient to Campylobacter, stool samples of the partner and the cat of the patient were analyzed and C. pinnepediorum/mucosalis/concisus and C. helveticus, respectively, were detected. The diversity in detected species in this immunocompromised patient with a lack of repeatedly consistent findings resulted in the conclusion that not any of the Campylobacter species was the primary cause of the clinical condition. This study shows the challenges in detection and interpretation of diagnostic results regarding Campylobacter.

2.
Ned Tijdschr Geneeskd ; 1642020 06 19.
Article in Dutch | MEDLINE | ID: mdl-32608929

ABSTRACT

Total parenteral nutrition may be considered for a carefully selected group of palliative patients with ileus. Predictive factors include a strong desire to live, low burden of disease other than the ileus and expected increase in quality of life as a result of starting with total parenteral nutrition. Therapy compliance is required and a strong social network is desirable. Close collaboration between hospital and general practitioners and frequent reviews of the palliative care plan are also required for success.


Subject(s)
Ileus/therapy , Intestinal Diseases/therapy , Palliative Care/methods , Parenteral Nutrition, Total/methods , Female , Humans , Ileus/psychology , Intestinal Diseases/psychology , Male , Palliative Care/psychology , Parenteral Nutrition, Total/psychology , Patient Compliance , Quality of Life , Social Support
3.
Am J Gastroenterol ; 113(6): 836-844, 2018 06.
Article in English | MEDLINE | ID: mdl-29700481

ABSTRACT

BACKGROUND: Eosinophilic esophagitis (EoE) is a chronic esophageal inflammation that may lead to stricture formation. This narrowing can cause major complications including food impactions. Despite increasing interest in EoE accurate data on its natural course is scarce. Therefore, we aimed to investigate the natural course of EoE and to evaluate the association between undiagnosed disease and the occurrence of complications over two decades in a large cohort. METHODS: We retrospectively analyzed charts of patients diagnosed with EoE between 1996 and 2015, collected from 15 hospitals throughout the Netherlands. Histologic, clinical, and endoscopic characteristics were identified and stratified by age and diagnostic delay. RESULTS: We included 721 patients (524 males, 117 children (≤18 years)). Dysphagia and food impactions were more common in adults whereas children more often presented with vomiting and abdominal pain (all p < 0.001). The prevalence of fibrotic endoscopic features was higher in adults (76%) than in children (39%) (p < 0.001). As time with undiagnosed disease progressed the percentage of patients with strictures and food impactions increased from 19% and 24% (diagnostic delay ≤ 2 years) to 52% and 57% (diagnostic delay ≥ 21 years) (p < 0.001), respectively. In a multivariate logistic regression model, diagnostic delay (odds ratio (OR) = 1.09; 95% confidence interval (CI) = 1.05-1.13) and male gender (OR = 2.69, 95% CI = 1.61-4.50) were the major risk factors for stricture presence. CONCLUSION: During the natural course of EoE, progression from an inflammatory to a fibrostenotic phenotype occurs. With each additional year of undiagnosed EoE the risk of stricture presence increases with 9%.


Subject(s)
Deglutition Disorders/epidemiology , Eosinophilic Esophagitis/complications , Esophageal Stenosis/epidemiology , Esophagus/pathology , Vomiting/epidemiology , Adolescent , Adult , Child , Deglutition Disorders/etiology , Delayed Diagnosis , Disease Progression , Eosinophilic Esophagitis/diagnosis , Eosinophilic Esophagitis/epidemiology , Eosinophilic Esophagitis/pathology , Esophageal Stenosis/diagnostic imaging , Esophageal Stenosis/etiology , Esophagoscopy , Esophagus/diagnostic imaging , Female , Fibrosis/diagnostic imaging , Fibrosis/epidemiology , Fibrosis/pathology , Humans , Male , Middle Aged , Netherlands/epidemiology , Prevalence , Retrospective Studies , Risk Factors , Sex Factors , Vomiting/etiology , Young Adult
4.
Dis Esophagus ; 30(2): 1-7, 2017 02 01.
Article in English | MEDLINE | ID: mdl-26919349

ABSTRACT

Various treatments are available for the palliation of esophageal cancer, but the optimal therapeutic approach is unclear. This study aimed to assess the palliative treatment modalities used in patients with inoperable esophageal cancer and to identify factors associated with treatment decisions. A population-based, retrospective cohort study was conducted using data from the nationwide Netherlands Cancer Registry and medical records of seven participating hospitals. Patients diagnosed with stage III-IV inoperable esophageal or gastric cardia cancer in the central part of the Netherlands between 2001 and 2010 were included. Logistic regression analyses were performed to identify determinants of treatment choices. In total, 736 patients were initially treated with best supportive care (21%), stent placement (19%), chemotherapy (18%), external beam radiotherapy (EBRT) (16%), brachytherapy (6%), a combination of EBRT and brachytherapy (6%), a combination of chemotherapy and EBRT (5%) or another treatment (9%). The palliative approach varied for disease stage (P < 0.01) and hospital of diagnosis (P < 0.01). Independent factors affecting treatment decisions were age, degree of dysphagia, tumor histology, tumor localization, disease stage, and hospital of diagnosis. For example, patients diagnosed in one hospital were less likely to be treated with EBRT than with stent placement compared to patients in another hospital (odds ratio 0.20, 95% confidence interval 0.07-0.59). In conclusion, the initial palliative approach of patients with inoperable esophageal cancer varies widely and is not only associated with patient- and disease-related factors, but also with hospital of diagnosis. These findings suggest a lack of therapeutic guidance and highlight the need for more evidence on palliative care strategies for esophageal cancer.


Subject(s)
Cardia/pathology , Esophageal Neoplasms/therapy , Palliative Care/methods , Patient Selection , Stomach Neoplasms/therapy , Aged , Antineoplastic Agents/therapeutic use , Brachytherapy/methods , Chemoradiotherapy/methods , Esophageal Neoplasms/pathology , Esophagus/surgery , Female , Humans , Logistic Models , Male , Middle Aged , Neoplasm Staging , Netherlands , Radiotherapy/methods , Registries , Retrospective Studies , Stents , Stomach Neoplasms/pathology , Treatment Outcome
5.
Endoscopy ; 46(1): 46-52, 2014 Jan.
Article in English | MEDLINE | ID: mdl-24218308

ABSTRACT

BACKGROUND AND STUDY AIMS: This study aimed to reassess whether the Forrest classification is still useful for the prediction of rebleeding and mortality in peptic ulcer bleedings and, based on this, whether the classification could be simplified. PATIENTS AND METHODS: Prospective registry data on peptic ulcer bleedings were collected and categorized according to the Forrest classification. The primary outcomes were 30-day rebleeding and all-cause mortality rates. Receiver operating characteristic curves were used to test whether simplification of the Forrest classification into high risk (Forrest Ia), increased risk (Forrest Ib-IIc), and low risk (Forrest III) classes could be an alternative to the original classification. RESULTS: In total, 397 patients were included, with 18 bleedings (4.5%) being classified as Forrest Ia, 73 (18.4%) as Forrest Ib, 86 (21.7%) as Forrest IIa, 32 (8.1%) as Forrest IIb, 59 (14.9%) as Forrest IIc, and 129 (32.5%) as Forrest III. Rebleeding occurred in 74 patients (18.6%). Rebleeding rates were highest in Forrest Ia peptic ulcers (59%). The odds ratios for rebleeding among Forrest Ib-IIc ulcers were similar. In subgroup analysis, predicting rebleeding using the Forrest classification was more reliable for gastric ulcers than for duodenal ulcers. The simplified Forrest classification had similar test characteristics to the original Forrest classification. CONCLUSION: The Forrest classification still has predictive value for rebleeding of peptic ulcers, especially for gastric ulcers; however, it does not predict mortality. Based on these results, a simplified Forrest classification is proposed. However, further studies are needed to validate these findings.


Subject(s)
Duodenal Ulcer/classification , Peptic Ulcer Hemorrhage/classification , Stomach Ulcer/classification , Aged , Aged, 80 and over , Area Under Curve , Duodenal Ulcer/complications , Female , Hemostasis, Endoscopic , Humans , Male , Middle Aged , Peptic Ulcer Hemorrhage/mortality , Peptic Ulcer Hemorrhage/therapy , Predictive Value of Tests , Prospective Studies , ROC Curve , Recurrence , Risk Assessment , Stomach Ulcer/complications
6.
Am J Gastroenterol ; 106(12): 2080-91; quiz 2092, 2011 Dec.
Article in English | MEDLINE | ID: mdl-22008891

ABSTRACT

Esophageal strictures are a common problem in gastroenterological practice. In general, the management of malignant or benign esophageal strictures is different and requires a different treatment approach. In daily clinical practice, stent placement is a commonly used modality for the palliation of incurable malignant strictures causing dysphagia, whereas, if available, intraluminal brachytherapy can be considered in patients with a good performance status. Recurrent dysphagia frequently occurs in malignant cases. In case of tissue in- or overgrowth, a second stent is placed. If stent migration occurs, the stent can be repositioned or a second (preferably partially covered) stent can be placed. Food obstruction of the stent lumen can be resolved by endoscopic cleansing. The cornerstone of the management of benign strictures is still dilation therapy (Savary-Gilliard bougie or balloon). There are a subgroup of strictures that are refractory or recur and an alternative approach is required. In order to prevent stricture recurrence, steroid injections into the stricture followed by dilation can be considered. In case of anastomotic strictures or Schatzki rings, incisional therapy is a safe method in experienced hands. Temporary stent placement is a third option before considering self-bougienage or surgery as a salvage treatment. In this review, the most frequently used endoscopic treatment modalities for malignant and benign stricture management will be discussed based on the available literature, and some practical information for the management in daily clinical practice will be provided.


Subject(s)
Esophageal Stenosis/therapy , Esophagoscopy/methods , Catheterization , Esophageal Stenosis/classification , Humans , Secondary Prevention , Stents
SELECTION OF CITATIONS
SEARCH DETAIL